FI890603A0 - Förfarande för framställning av en HIV-partikelimmunogen och dess antikropp - Google Patents

Förfarande för framställning av en HIV-partikelimmunogen och dess antikropp

Info

Publication number
FI890603A0
FI890603A0 FI890603A FI890603A FI890603A0 FI 890603 A0 FI890603 A0 FI 890603A0 FI 890603 A FI890603 A FI 890603A FI 890603 A FI890603 A FI 890603A FI 890603 A0 FI890603 A0 FI 890603A0
Authority
FI
Finland
Prior art keywords
immunogen
hiv
retrovirus
infectious
useful
Prior art date
Application number
FI890603A
Other languages
English (en)
Finnish (fi)
Other versions
FI95871C (sv
FI890603A (sv
FI95871B (sv
Inventor
Jonas Salk
Dennis J Carlo
Original Assignee
Immune Response Corp Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immune Response Corp Inc filed Critical Immune Response Corp Inc
Publication of FI890603A0 publication Critical patent/FI890603A0/sv
Publication of FI890603A publication Critical patent/FI890603A/sv
Application granted granted Critical
Publication of FI95871B publication Critical patent/FI95871B/sv
Publication of FI95871C publication Critical patent/FI95871C/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
    • A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
    • A61M1/3687—Chemical treatment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16111—Human Immunodeficiency Virus, HIV concerning HIV env
    • C12N2740/16122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Information Retrieval, Db Structures And Fs Structures Therefor (AREA)
FI890603A 1987-06-10 1989-02-08 Förfarande för framställning av en HIV-partikelimmunogen och dess antikropp FI95871C (sv)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US6028087A 1987-06-10 1987-06-10
US6028087 1987-06-10
US20075288A 1988-05-31 1988-05-31
US20075288 1988-05-31
US8801955 1988-06-09
PCT/US1988/001955 WO1988009670A1 (en) 1987-06-10 1988-06-09 Prevention and treatment of retroviral disease

Publications (4)

Publication Number Publication Date
FI890603A0 true FI890603A0 (sv) 1989-02-08
FI890603A FI890603A (sv) 1989-02-08
FI95871B FI95871B (sv) 1995-12-29
FI95871C FI95871C (sv) 1996-04-10

Family

ID=26739775

Family Applications (1)

Application Number Title Priority Date Filing Date
FI890603A FI95871C (sv) 1987-06-10 1989-02-08 Förfarande för framställning av en HIV-partikelimmunogen och dess antikropp

Country Status (14)

Country Link
EP (3) EP0685236A1 (sv)
JP (1) JPH0720880B2 (sv)
AT (1) ATE132374T1 (sv)
AU (1) AU612383B2 (sv)
CA (1) CA1336407C (sv)
DE (1) DE3854857T2 (sv)
DK (1) DK56389D0 (sv)
FI (1) FI95871C (sv)
IL (1) IL86675A (sv)
NO (1) NO175846C (sv)
OA (1) OA09037A (sv)
RU (1) RU2111010C1 (sv)
UA (1) UA27716C2 (sv)
WO (1) WO1988009670A1 (sv)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ223980A (en) * 1987-03-23 1991-02-26 Hiver Ltd An aids-type virus vaccine comprising an antibody equivalent which recognises an epitope on a cd4 cell-marker
US5256767A (en) * 1987-06-10 1993-10-26 The Immune Response Corporation Retroviral antigens
US5227159A (en) * 1989-01-31 1993-07-13 Miller Richard A Anti-idiotype antibodies reactive with shared idiotopes expressed by B cell lymphomas and autoantibodies
DE69029135T2 (de) * 1989-05-30 1997-05-28 Nippon Zeon Co Verfahren zur herstellung von kernstrukturen von retroviren und dadurch hergestellte partikel
FR2661834B1 (fr) * 1990-05-09 1995-01-27 Merieux Inst Procede de fabrication d'immunogenes de retrovirus et de vaccins contre les infections retrovirales, notamment hiv, et immunogenes et vaccins obtenus.
AU4685293A (en) * 1992-07-20 1994-02-14 Immune Response Corporation, The Prophylactic and therapeutic control of retroviral infections
AU2127395A (en) * 1994-03-22 1995-10-09 Rhone-Poulenc Rorer Pharmaceuticals Inc. Highly efficient production and isolation of viral particles
IT1271593B (it) * 1994-11-30 1997-06-04 Sanitaria Scaligera Spa Procedimento ed apparecchiatura per l'immunoadsorbimento specifico di virus hiv, di antigene gp120 e complesso cd4-gp120.

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4716102A (en) * 1984-08-15 1987-12-29 Regents Of The University Of California Purified AIDS-associated virus ARV-2
DK507185A (da) * 1984-11-05 1986-05-06 Du Pont Fremgangsmaade til inaktivering af human tumor leukaemi virus iii
US4725669A (en) * 1984-11-09 1988-02-16 President And Fellows Of Harvard College Assay for detecting infection by human T-cell lymphotropic virus-III
ATE138100T1 (de) * 1984-12-24 1996-06-15 Genentech Inc Fusionen von aids-verwandten polypeptiden
ATE109512T1 (de) * 1985-04-08 1994-08-15 Genetic Systems Corp Expression und diagnose mit gag-kodierten peptiden, die mit antikörpern gegen lav immunologisch reaktiv sind.
DK171119B1 (da) * 1985-04-19 1996-06-17 Hoffmann La Roche AIDS-viruskappeprotein, ekspressionsvektor bærende viruskappeproteinet, transformanter transformeret med ekspressionsvektoren, fremgangsmåde til fremstilling af viruskappeproteinet, fremgangsmåde til detektion af AIDS-antistoffer, fremgangsmåde til bestemmelse af AIDS-virus, vaccine mod AIDS, antistoffer mod viruskappeproteinet samt anvendelse af dette til fremstilling af en vaccine og til testnin
WO1987002892A1 (en) * 1985-11-14 1987-05-21 President And Fellows Of Harvard College T-lymphotrophic virus
EP0250128A3 (en) * 1986-06-18 1988-06-08 American Registry of Pathology Novel virus isolated from patients with aids
CA1341277C (en) * 1987-03-16 2001-07-31 Roland Keith Mcgready Anti-paratopic antibody and a method of its manufacture

Also Published As

Publication number Publication date
FI95871C (sv) 1996-04-10
NO890565D0 (no) 1989-02-09
IL86675A (en) 1993-04-04
NO175846B (sv) 1994-09-12
DE3854857T2 (de) 1996-08-22
AU1962688A (en) 1989-01-04
EP0685236A1 (en) 1995-12-06
RU2111010C1 (ru) 1998-05-20
DK56389A (da) 1989-02-08
JPH0720880B2 (ja) 1995-03-08
AU612383B2 (en) 1991-07-11
DE3854857D1 (de) 1996-02-15
ATE132374T1 (de) 1996-01-15
EP0602761A1 (en) 1994-06-22
FI890603A (sv) 1989-02-08
NO890565L (no) 1989-02-09
JPH02500440A (ja) 1990-02-15
EP0317622B1 (en) 1996-01-03
DK56389D0 (da) 1989-02-08
EP0317622A4 (en) 1990-05-14
FI95871B (sv) 1995-12-29
OA09037A (en) 1991-03-31
CA1336407C (en) 1995-07-25
WO1988009670A1 (en) 1988-12-15
UA27716C2 (uk) 2000-10-16
EP0317622A1 (en) 1989-05-31
NO175846C (no) 1994-12-21

Similar Documents

Publication Publication Date Title
DE69535075D1 (de) Antigen-markierte nicht-infektiöse retrovirus-ähnlige partikel
ATE144143T1 (de) Künstlicher impfstoff gegen aids-virus
DK0584348T3 (da) Genetisk vaccine mod immundefektvirusser
RU94042386A (ru) Вакцина против гепатита, содержащая 3-0-дезацилированный монофосфорил-липида, применение антигена гепатита для получения препарата для лечения гепатита, способ лечения гепатита
AU2684792A (en) Porcine reproductive respiratory syndrome vaccine and diagnostic
SE9102974L (sv) Adenovira och vaerd till anvaendning foer framstaellning av hiv-proteiner och peptider
DE69131200T2 (de) Herpes simplex virus vp16 impfstoffe
FI842215A (fi) Foerfarande foer framstaellning av levande effektiveringsvaccin och pao detta saett erhaollna vaccin.
FI890603A0 (sv) Förfarande för framställning av en HIV-partikelimmunogen och dess antikropp
JPS5726624A (en) Isolation of virus glycoprotein antigen and manufacture of vaccine thereby
ATE188484T1 (de) Immunologisch mit hla homologe hiv protein epitope
DE3889581D1 (de) Monoklonale Antikörper gegen spezifische antigene Regionen des humanen Immundefizienzvirus und Methoden zur Verwendung.
HUP0202770A2 (hu) Humán papillómavírus oltóanyag
ATE283066T1 (de) Impfstoff enthaltend zytokin-induzierte heat shock proteine (hsp)
CA2133108A1 (en) Pasteurella haemolytica type a-1 bacterin-toxoid vaccine
SE8701765L (sv) Analysmetod och medel foer denna
HUP0003511A2 (hu) Hepatitisz-B-vírus polipeptidek
EP0250128A3 (en) Novel virus isolated from patients with aids
EP0320034A3 (en) New immunologically active synthetic peptides useful for preparing an antimalarial vaccine
EP0309898A3 (en) Method for the induction of a cytotoxic t cell response
EP0513371A4 (en) Human parainfluenza virus type 4a fusion protein and gene which codes for the same
Zourbas et al. Immunization of dental surgeons against hepatitis B virus infection.
AU6791290A (en) Antigens relating to envelope glyoprotein of the virus of aids, particularly precursors of this glycoprotein, methods of obtaining these antigens and means employed in these methods, applications of these antigens in the preparation of immunogenic compositions or for the diagnosis of aids or

Legal Events

Date Code Title Description
BB Publication of examined application
FG Patent granted

Owner name: THE IMMUNE RESPONSE CORPORATION, INC.

MA Patent expired